StockNews.com Initiates Coverage on Concord Medical Services (NYSE:CCM)

Analysts at StockNews.com started coverage on shares of Concord Medical Services (NYSE:CCMGet Free Report) in a note issued to investors on Friday. The firm set a “sell” rating on the stock.

Concord Medical Services Price Performance

NYSE CCM opened at $5.48 on Friday. The company’s fifty day simple moving average is $6.66 and its 200-day simple moving average is $7.13. Concord Medical Services has a 52 week low of $3.82 and a 52 week high of $26.70. The company has a debt-to-equity ratio of 1.15, a current ratio of 0.47 and a quick ratio of 0.46.

Concord Medical Services Company Profile

(Get Free Report)

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.

See Also

Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.